Ruxolitinib Controls Lymphoproliferation and Diabetes in a STAT3-GOF Patient.

J Clin Immunol

Faculty of Medicine, Center for Pediatrics and Adolescent Medicine, Medical Center, University of Freiburg, Mathildenstr 1, 79106, Freiburg, Germany.

Published: November 2020

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7567728PMC
http://dx.doi.org/10.1007/s10875-020-00864-wDOI Listing

Publication Analysis

Top Keywords

ruxolitinib controls
4
controls lymphoproliferation
4
lymphoproliferation diabetes
4
diabetes stat3-gof
4
stat3-gof patient
4
ruxolitinib
1
lymphoproliferation
1
diabetes
1
stat3-gof
1
patient
1

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!